Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.13733
Abstract: gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther 2013; 38: 563–572. 4 Jaimes-L opez N, Molina V, Arroyave JE et al. Development of pyoderma gangrenosum during therapy with infliximab. J Dermatol… read more here.
Keywords: syndrome unexpected; lysis syndrome; adverse event; tumour lysis ... See more keywords